http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2052980-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5bf3224236325d34b6c84558b906954
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-92
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 1980-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1981-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2052980-A
titleOfInvention Pharmaceutical composition for oral administration comprising methoxsalen
abstract Solutions of 8-methoxyfuro- (3',2': 6,7)-coumarin in a polyethylene glycol or an ether or ester thereof, a derivative of 3-dioxolane; an alkylene glycol; a pharmaceutically acceptable ethereal oil; an ester or partial ester of a C2 to C30 fatty acid with a 2- to 8- valent alcohol or with a polyglyceride; or a dialkyl amide having 3 to 6 carbon atoms; or dimethyl sulphoxide; or a mixture thereof give more rapid onset of blood level maxima. Such solutions have utility in the treatment of psoriasis by photochemotherapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9816195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0172893-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0039874-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0172893-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-591107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0392429-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5036102-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0039874-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0197856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0174958-A4
priorityDate 1979-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415814097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555532

Total number of triples: 46.